Brand-Name Lipitor at Generic Prices

Patients saw steep discounts on Lipitor when manufacturer Pfizer lost its patent last year. But will other manufacturers slash prices on name-brand drugs?

You can usually save big by switching from a brand-name drug to a generic. But when Lipitor lost its patent late last year, the results were surprising. Manufacturer Pfizer had spent years negotiating deals with health plans to keep costs for its blockbuster cholesterol-lowering drug competitive with the generic alternative. Now, some users get Lipitor on the cheap. But what you pay for Lipitor and other popular off-patent drugs may vary depending on your health care plan.

When a generic is introduced, it typically sells for about 10% to 15% less than the average wholesale price for the brand-name drug. That held true when Lipitor came off-patent, says Jim Yocum, of DestinationRx, which creates drug-comparison tools for insurers and consumers. But if you have insurance, your out-of-pocket costs are based on the insurer’s pricing tier for the drug -- with the unusual twist that you might pay the same for Lipitor as you’d pay for the generic.

Most health plans have three tiers of drug pricing. You may pay $10 per month or 10% of the cost of drugs in Tier 1 (primarily generics), $20 per month or 40% in Tier 2 (preferred brand-name drugs), and $40 per month or 60% in Tier 3 (nonpreferred brand-name drugs). In 2011, most plans included Lipitor in Tier 2. Since then, many plans have switched it to Tier 1. Indications are that Pfizer has been using rebates to retain market share, says Yocum. Check the pricing for your own plan; some plans have moved Lipitor to Tier 3, making it more expensive.

Subscribe to Kiplinger’s Personal Finance

Be a smarter, better informed investor.

Save up to 74%
https://cdn.mos.cms.futurecdn.net/hwgJ7osrMtUWhk5koeVme7-200-80.png

Sign up for Kiplinger’s Free E-Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

Drug companies are waiting to see whether Pfizer’s discounting can preserve Lipitor’s market share -- a key question as several other big-name drugs, including Lexapro, Plavix and Singulair, go off patent in the next few months. If you take a drug that is coming off patent, check your plan’s prices for the generic. Also check options for staying with the brand-name drug, including any rebates from the drug company.

Kimberly Lankford
Contributing Editor, Kiplinger's Personal Finance

As the "Ask Kim" columnist for Kiplinger's Personal Finance, Lankford receives hundreds of personal finance questions from readers every month. She is the author of Rescue Your Financial Life (McGraw-Hill, 2003), The Insurance Maze: How You Can Save Money on Insurance -- and Still Get the Coverage You Need (Kaplan, 2006), Kiplinger's Ask Kim for Money Smart Solutions (Kaplan, 2007) and The Kiplinger/BBB Personal Finance Guide for Military Families. She is frequently featured as a financial expert on television and radio, including NBC's Today Show, CNN, CNBC and National Public Radio.